SPY752.51−0.02%QQQ678.22−0.17%BTC/USD74,670.50−0.78%DIA523.41+0.02%GLD377.85−0.44%TLT81.84−0.15%
BenzingaPremium Services
Premium Services
Updated: Nov 10, 2026

Analyst Stock Ratings

Analyst downgrades are often a bearish signal for a stock. When an analyst downgrades a stock it means the stock rating is lower than it previously was and the analyst likely does not recommend people buy the stock.

Get Alert
Nov 9, 2026
MNDYMonday.Com
$80.42Get Alert
Nov 9, 2026
NXHNeighborhood Intelligence
$1.51—Get Alert
Nov 9, 2026
DKNGDraftKings
$18.80Get Alert
Nov 9, 2026
QCOMQualcomm
$170.51Get Alert
Nov 9, 2026
SMASmartstop Self Storage
$38.05Get Alert

Recent Analyst Stock Rating Downgrades News

Iambic Therapeutics Jumps 17% After-Hours as Wall Street Turns Bullish on Its AI-Powered Drug Discovery Platform
Iambic Therapeutics Jumps 17% After-Hours as Wall Street Turns Bullish on Its AI-Powered Drug Discovery Platform
Iambic Therapeutics shares surge as BofA and Jefferies initiate coverage with Buy ratings and bullish price targets.
Sally Beauty Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Sally Beauty Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Sally Beauty is expected to report Q4 EPS of 60 cents and revenue of $950M; analysts are mixed.
Top Wall Street Forecasters Revamp Bitdeer Expectations Ahead Of Q3 Earnings
Top Wall Street Forecasters Revamp Bitdeer Expectations Ahead Of Q3 Earnings
Bitdeer will report Q3 earnings Tuesday, with analysts expecting a 33-cent loss per share and $258.19M revenue.
PRO
Loop Capital Maintains Hold on Monday.Com, Lowers Price Target to $90
Loop Capital analyst Mark Schappel maintains Monday.Com (NASDAQ:MNDY) with a Hold and lowers the price target from $100 to $90.
PRO
Canaccord Genuity Downgrades Monday.Com to Hold, Lowers Price Target to $90
Canaccord Genuity analyst David Hynes downgrades Monday.Com (NASDAQ:MNDY) from Buy to Hold and lowers the price target from $115 to $90.
PRO
Leerink Partners Maintains Outperform on Veradermics, Raises Price Target to $150
Leerink Partners analyst Marc Goodman maintains Veradermics (NYSE:MANE) with a Outperform and raises the price target from $135 to $150.
PRO
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $333
Lake Street analyst Ben Haynor maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $310 to $333.
PRO
Ladenburg Thalmann Maintains Neutral on Apple Hospitality REIT, Raises Price Target to $19
Ladenburg Thalmann analyst Floris Van Dijkum maintains Apple Hospitality REIT (NYSE:APLE) with a Neutral and raises the price target from $18 to $19.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved